Autophagy signaling pathway is involved in cellular homeostasis, developmental processes, cellular stress responses, and immune pathways. The aim of this review is to summarize the relationship between autophagy and viruses. It is not possible to be fully comprehensive, or to provide a complete "overview of all viruses". In this review, we will focus on the interaction of autophagy and viruses and survey how human viruses exploit multiple steps in the autophagy pathway to help viral propagation and escape immune response. We discuss the role that macroautophagy plays in cells infected with hepatitis C virus, hepatitis B virus, rotavirus gastroenteritis, immune cells infected with human immunodeficiency virus, and viral respiratory tract infections both influenza virus and coronavirus. Autophagy (from the Greek, "auto" meaning oneself, "phagy" meaning to eat) is a conserved intracellular homeostatic process where waste cellular components and infectious agents are surrounded by a double layer membrane to create a compartment called the phagosome.
| INTRODUCTION
The presence of numerous membrane-enclosed structures is the most remarkable morphological feature of eukaryotic cells. 1 Macroautophagy is one of the best examples of membrane mobilization which occurs during the process of self-degradation of cellular component pathway in the cytoplasm. This process aids cell survival in response to multiple stress situations such as nutrient or growth factor deprivation, reactive oxygen species (ROS), hypoxia, and the presence of intracellular pathogens. 2 Autophagy (from the Greek, "auto" meaning oneself, "phagy" meaning to eat) is a conserved intracellular homeostatic process where waste cellular components and infectious agents are surrounded by a double layer membrane to create a compartment called the phagosome. 3 The phagosome then is delivered and fuses with the lysosome compartments to degrade its contents. 4 The double layer membrane (phagophore) is most likely originated from a lipid bilayer donated by the endoplasmic reticulum (ER) and/or the trans-Golgi. 5 Autophagy is as a cellular recycling mechanism that generates ATP and controls damage by removing non-functional proteins and organelles. 6 In addition to its homeostatic role, autophagy also functions in caspase-independent autophagic cell death, a subset of type II programmed cell death.
Autophagic cell death is characterized by the extensive sequestration of portions of the cytoplasm into autophagosomes, giving the cell a characteristic vacuolated appearance.
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| History of autophagy
In 1962, Ashford and Porter detected membrane-bound vesicles encompassing semi-digested mitochondria and ER in the hepatocytes of rats that had been treated with glucagon. 9 One year later, in 1963, at the Ciba Foundation symposium on lysosomes, Christian de Duve coined the term "autophagy" to define the presence of single-membrane or double-membrane vesicles that contain parts of the cytoplasm and organelles. 10 Studies into the molecular control of autophagy, starting in the early 1990s by pioneering work from
Ohsumi's group reported that the morphology of autophagy in yeast was similar to that recognized in mammals. 11 In addition, several selective modes of autophagy such as lipophagy (the autophagy-mediated degradation of lipid droplets) and mitophagy (selective degradation of mitochondria by autophagy) were first proposed based on the experiments with cultured hepatocytes and whole livers.
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| Autophagy steps
Three forms of autophagy that play different physiological functions have been identified: chaperone-mediated autophagy, microautophagy, and macroautophagy. 6 This review focuses on the mutual interaction between viruses and macroautophagy (hereafter autophagy). Currently, 40 autophagy-related genes (ATG) have been discovered and characterized. 16, 17 There are 5 key steps in autophagy:
(1) phagophore formation and nucleation; (2) conjugation of Atg5-Atg12 complex, interaction with Atg16L and polymerization of the complex Atg12-Atg5/Atg16L at the immature phagophore; (3) extension of the phagophore membrane by microtubule-associated protein 1 light chain 3 alpha (LC3) processing and insertion; (4) engulfing of random or selective targets for degradation; and (5) fusion with the lysosome to form autolysosome, followed by proteolytic degradation of captured contents by lysosomal proteases of captured contents. 18 
| Autophagy induction
Autophagy induction is regulated through 3 main pathways. The first pathway takes place by mammalian target of rapamycin (mTOR), a serine/threonine-specific protein kinase, and negatively modulates autophagy. 19 The mTOR inhibits serine/threonine-protein kinase ULK1 from recruiting its partners to form the autophagosome. 20, 21 TOR, a vital regulator of cell growth, plays an important role in cell growth and autophagy formation in response to nutritional status.
During lack of nutrients, AMP protein-activated kinase (AMPK) negatively regulates mTOR and results in autophagy induction. 22 However, in response to insulin or growth factors, class I phosphatidylinositol 3-kinase (PI3K)-triggered phosphorylation of protein kinase B (also known as Akt) activates mTOR, thus inhibiting autophagy.
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Atg6/Beclin-1 is involved in the second pathway of autophagy induction. The interaction of Beclin-1 with vesicular protein sorting 34 (Vps34) stimulates the catalytic function of Vps34 and increases levels of phosphatidylinositol triphosphate. 23 Vps34 is specifically involved in autophagy when it interacts with Beclin-1. 24 Vps34 only phosphorylates phosphatidylinositol (PI) as substrate to generate phosphatidylinositol triphosphate, which is indispensable for phagophore elongation and recruitment of auxiliary Atg proteins to the phagophore. 23 Furthermore, Beclin-1 is a binding partner of the anti-apoptotic protein B-cell chronic lymphocytic leukemia/ lymphoma 2 (Bcl-2) protein, and BCL2-bound Beclin-1 is inaccessible for autophagosome formation. 25 Antagonistic interactions between viral proteins and Beclin-1 subvert autophagosome formation and maturation by blocking fusion with lysosomes and exacerbating virulence. 26 Other regulatory proteins, such as Rubicon, UV radiation resistanceassociated gene (UVRAG), BIF-1, Atg14L, and Ambra, form complexes with Vps34 and Beclin-1 at the ER and nucleated phagophore to both stimulate and suppress autophagy.
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The third pathway that contributes to autophagosome formation and elongation involves ubiquitin-like conjugation processes that generate membrane-bound protein complexes. 30 Atg7 and Atg10 mediate the conjugation of Atg12 to Atg5, which subsequently interact with Atg16. The Atg12-Atg5/Atg16L complex binds to the outer membrane of autophagosome and then dissociates upon completion of the autophagosome. 31 The second conjugation reaction involves to the dynamic turnover of LC3-II via the lysosomal activity. 33, 34 In this process, LC3-I is covalently conjugated to phosphatidylethanolamine through LC3 lipid coupling mechanism, resulting in LC3-II. LC3-II then moves from the cytosol to the autophagosome membranes 34, 35 where it remains associated with the expanding limiting membrane, sealed autophagosomes, and mature autophagosomes/autolysosomes. [36] [37] [38] Thus, LC3-II levels usually correlate with autophagosome numbers. 34 To evaluate if substrate degradation is autophagy dependent, it is useful to perform assays measuring LC3-II levels assays in the presence and absence of a lysosomal vacuolar-type H(+)-ATPase inhibitor such as Bafilomycin A1 (Baf-A1). 38 
| VIRUSES AND AUTOPHAGY
Autophagy acts as a double-edged sword in pathogenesis of viral disease. 39 Xenophagy describes autophagy that serves as an innate immune response to eliminate intracellular infectious pathogens. 40 Hosts deficiency in autophagy are prone to microbial infections. 41 Autophagy occurs at basal levels to maintain cellular homeostasis, but the stress of viral infection can trigger autophagy induction. During infection, autophagy can play either a pro-viral or antiviral role, depending on the virus, the cell type, and the cellular environment. 42, 43 Autophagy can function differently in response to positive-strand and negative-strand RNA viruses, DNA viruses, viral genotypes, step of viral life cycle, and stage of pathogenesis. 44 During host cell infection, viruses and viral proteins can be targeted for degradation by autophagy to stop viral replication. Conversely, some viruses have evolved strategies to avoid autophagy-induced lysosomal degradation by subverting autophagy into autophagosomal shelters harboring viral replication. In fact, these viruses exploit the autophagy pathway by replicating in the autophagosome-like structures themselves. [45] [46] [47] [48] [49] [50] [51] [52] [53] Manipulation of autophagy can be a promising strategy to eliminate intracellular pathogens. 38 
| Antiviral function of autophagy and the role of autophagy in suppression of anti-viral immune response
Autophagy is an integral part of immune response to viral infections and plays a key role both in innate and adaptive immunity responses.
Autophagy is essential for delivering cytoplasmic viral RNA to the endosomal pathway through unique ability to deliver cytosolic pathogen-associated molecular patterns into the closeness of endosomal pattern recognition receptors (PRRs) and MHC loading compartments.
For example, influenza viruses are sensed in the lysosomes of plasmacytoid dendritic cells (pDCs) through TLR7 after endocytosis of virions. 54 Human immunodeficiency virus (HIV) 1 can escape immune system through a new mechanism in DCs. HIV-1 was revealed to block macroautophagy initiation via inducing the mTOR pathway. 67 Upon binding to the host cell, HCV is internalized through clathrin-mediated endocytosis. 68 To release the viral nucleocapsid into the cytoplasm, the viral and endosomal membranes fuse in a pH-dependent manner. 69 HCV RNA is transported to the ER, where HCV non-structural proteins NS4B and NS5A induce ER membrane alteration (known as "membranous web" formation). This alteration provides a scaffold for the replication of the HCV and protects the virus from host immune defenses. 70 HCV NS4B, a membranous web formation inducer, may elicit a stress response that triggers autophagy as shown in Figure 1 . 71 Autophagy that is basal, rather than stress-induced, may provide an initial membranous platform for incoming RNA translation. Once replication is established, this platform becomes unnecessary for translation of HCV RNA progeny. 72 Growing tence. 77 The HCV core protein has been revealed to stimulate both the ATF6 and PERK pathways that, in turn, enhance the expression of the ATG12 and LC3 genes. 78 Induction of autophagy and mitophagy is essential to sustain the survival of infected cells and establish a chronic HCV infection. 77 Interaction between autophagy and HCV is time dependent. The co-localization of ATG5 and HCV RNA polymerase NS5B is detected 48 hours following infection. In contrast after 5 days post-infection, the co-localization has disappeared. 79 In the normal autophagic path- 
| HBV interaction with autophagy
Hepatitis B virus (HBV), a member of the Hepadnaviridae family, with a DNA virus that infects hepatocytes, enhances and recruits autophagy in favor of its DNA replication. 88 HBV is responsible for one of the most common chronic infections of the liver in humans, and chronic hepatitis caused by HBV is the main etiologic agent of hepatocellular carcinoma. 89 HBV small envelope proteins (SHBs) mediate ER stress and UPR induction, and the effect of SHBs on autophagy was eliminated when the 3 sensors of ER stress (ie, IRE1, PERK, and ATR6) were silenced with siRNAs. 90 Recently, it has been verified that HBV is able to activate the ER-associated degradation pathway and trigger the expression of ER degradation-enhancing mannosidase-like proteins, which then facilitate the degradation of HBV surface proteins through the autophagic pathway. 91 Autophagy dysfunction has been related to several diseases including cancer. However, a recent report showed that in HBV-associated hepatocellular carcinoma (HCC), autophagy was downregulated,
The cross-talk between autophagy and HCV. The hepatitis C virus (HCV) induces autophagy to enhance virus replication rather than to block it. After HCV decapsidation, the virus genome is transferred to endoplasmic reticulum (ER) and initiates replication in the ER-derived membranous web as the HCV replication platform. HCV-induced ER stress disrupts ER function and results in accumulation of unfolded proteins in the ER. Cells adapt to ER stress by triggering an unfolded protein response (UPR) to restore ER homeostasis. The UPR signaling pathway includes 3 central elements, PKR-like ER kinase (PERK), ATF6, and IRE1. The UPR could stimulate an autophagy response. Under these conditions, calcium released from the ER stimulates impaired mitochondrial activity connect to excessive production of ROS. Dysfunctional mitochondria are engulfed for degradation via mitophagy. In addition, HCV promoted dynamin-related protein 1-mediated mitochondrial fission protein 1 (Drp1) leads to mitophagy. HCV replication takes place in close proximity to lipid droplets (LDs), the neutral lipid storage organelles, and this closeness enables the downstream viral morphogenetic events. A selective autophagy for lipids (lipophagy) protects cells from an excessive lipid accumulation elicited by HCV. Upon HCV infection, the host stimulates the antiviral interferon-mediated frontline. HCV employs autophagy to escape host innate immune surveillance by inhibiting IFNα production. Furthermore, HCV replication reduced ribavirin uptake, due to reduced expression of the nucleoside transporters ENT1 and CNT1
and there was a reverse relation between the autophagic activity and the level of microRNA-224 (miR-224) in these tumor cells. 92 Autophagosomes can sequester miR-224 and subsequently degrade it. Increased miR-224 results in downregulation of its target gene Smad4, a transcription factor that activates the TGF-β signaling pathway. 92 Smad4 inhibition can shift TGF-β's role from a tumor suppressor to a tumor enhancer factor. 93 The induction of autophagy is mediated by HBV X-Protein (Trans-Activator X Gene) through interaction and activation of phosphatidylinositol-3-kinase class 3 (PI3KC3). 88 
| Rotaviruses and autophagy
Rotavirus consists of 11 segments of double-stranded RNA 94 and causes age-dependent and life-threatening dehydrating viral gastroenteritis in children worldwide. The full mechanism by which rotavirus induces diarrhea remains unclear, but it is triggered to some extent by virus-encoded non-structural protein 4 (NSP4), which acts as a viral enterotoxin through viroporin activity. 95, 96 During rotavirus infection, NSP4 co-localizes with the LC3 protein and surrounds viroplasms, the viral factories in the cell. 97 Rotavirus hijacks the autophagy membrane trafficking pathway through NSP4 to transfer ER-associated viral proteins NSP4 and VP7 to virus producing viroplasms. 64 The interaction of NSP4 with immature virus particles at the boundary between viroplasms and NSP4/LC3-containing membranes mediates the assembly of the outer capsid proteins onto the double-layered particle, finally forming the infectious virion which is a triple-layered par- autophagosome maturation in infected macrophages through its association with Beclin 1, thereby avoiding degradation. 22 In DCs, HIV-1
Env has been proposed to increase cell-associated HIV-1 by activating mTOR and S6-kinase (S6K), thus inhibiting autophagy and transferring infection into CD4 + T cells (trans-infection).
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Cells belonging to the monocyte-macrophage lineage are more resistant to cytopathic effects and are able to harbor viruses for longer time periods. A study by Espert et al demonstrated the resistance of macrophages to HIV Env-mediated bystander cell death, in contrast to CD4 + T cells. 123 The secreted form of HIV-Tat blocks autophagy by activating Src-Akt and STAT3 signaling pathways, previously known to inhibit authophagy. 60 Moreover, HIV-Tat induces production of IL-10. 129 Interestingly, IL-10 inhibits autophagy initiation in uninfected bystander macrophages, independently of the presence of Env. 60 The
Tat protein also dysregulates IFN-γ signaling and suppresses autophagy in macrophages. The protein inhibits STAT1 phosphorylation and reduces upregulation of LC3B and autophagosome formation. Additionally, HIV-Tat restricts mycobacteria capture by autophagosomes, thereby providing a favorable environment for opportunistic microbes in HIV-infected individuals. 130 Furthermore, the HIV-1 precursor Gag co-localized and interacted with the autophagy factor LC3, suggesting that autophagy promoted productive Gag processing and viral particle production in macrophages. to HIV-1. 134 The ability of NK cells to lyse infected cells is increased by IFN-α. 135 Thus, autophagy is required for suppression of HIV-1 replication by cytolytic function of the innate immune system.
| Autophagy in HIV-associated neurological disorders
The CNS is considered to be a viral reservoir, because antiretroviral therapy drugs have limited access to this area. [136] [137] [138] There are several lines of evidence that suggest that brain cells harbor genome-integrated HIV. 139 HIV-associated neurological disorders occur almost immediately after systemic infection. 140 Moreover, dysregulated autophagy also contributes to agingrelated neuropathology in HIV patients who develop HAND. 145 These results are similar to the bystander effect of HIV-1 Env that increases autophagy in CD4 + cell, described previously.
In addition to gp120, the HIV-1 transactivator protein Tat causes neuronal injury. One study suggests that Tat contributes to HIV-1 neuropathogenesis by altering the autophagy pathway. 146 The authors
show that Tat induces autophagic degradation by promoting fusion of autophagosomes and lysosomes, leading to abnormal neuronal autophagy and dysregulated degradation of critical intracellular components. 
| Cross-talk between influenza virus and autophagy
Influenza A virus (IAV) (family Orthomyxoviridae, genus Influenza virus A) has caused severe respiratory diseases for hundreds of years in humans and different animal species, resulting in considerable morbidity and mortality. 150 IAVs are multi-step infectious agents that recruit host cell machinery to support the replication and transportation of their own viral components. 151, 152 Understanding this viral strategy requires characterization of the intracellular pathways by which the influenza virus replicate. 151 Here, we focus on autophagy as one of the most prominent processes involved in the efficient replication of IAV inside the host cell.
Autophagy was originally characterized as a critical process for influenza virus replication. This infection triggers autophagy in different types of cells and enhances autophagosome formation and autophagic flux. 153 Baf-A1 is a highly specific inhibitor for vacuolartype proton (V-H+) pumps, which are responsible for the acidification of endosomes and lysosomes, and are necessary for influenza virus replication. 154 Administration of Baf-A1 at low concentrations effectively inhibits IAV replication without impacting host cell viability. 155 This dose of Baf-A1 inhibits the formation of autophagosomes, resulting from either an inhibition of autophagosome formation or an increase in degradative flux. However, the most common scenario with an inhibitor of autophagy like Baf-A1 is an increase in levels of LC3-II, and is indicator of increased autophagosome formation. 38 In addition, autophagy may act as an innate immune mechanism to restrict virus replication. 156 Autophagy inhibition by IAV can be considered a novel immune escape mechanism or a by-product of altered autophagosome physiology. If the viral escape mechanism is broken, virus replication and virulence are impaired 37, 157, 158 suggesting that induction of autophagosome degradation during viral infections might restrict virus replication within infected cells. 159 Viruses can upregulate autophagosome formation, or, alternatively, autophagosome degradation in lysosomes could be blocked. Several pieces of evidence support the latter scenario, whereby after influenza infection, autophagosomes do not fuse with acidic compartments. 160 Blocking autophagosome degradation would lead to accumulation of autophagosomes and LC3-II 48, 160 to evade presentation of viral antigens. 48, 160 It has been reported that autophagy is involved in the replication of IAV, and inhibiting autophagy will inhibit the replication of this virus. 161 In 2007, Dorothee Schmid found that autophagy in IAV-infected lung epithelial cells is inhibited. Autophagosomes accumulate because they do not fuse with lysosomes, leading to increased virus survival. 36 A study on the antiviral activity of statins found that the expression level of LC3-II was independent of the presence of Baf-A1, confirming that influenza virus increases autophagosome formation by LC3-II accumulation and inhibits autophagosome maturation. 162 Two viral proteins, NS1 and M2, are associated with autophagy signaling. NS1 binds to p85β, the regulatory subunit of PI3K, 163 while M2 keeps autophagy at moderate levels by limiting the degree of lysosome fusion with autophagosomes. 160 M2 protein, a virus-specific membrane protein, 164 is expressed at the surface of infected cells. It has a short (24 residues long), highly conserved extracellular N-terminal domain, an internal hydrophobic anchorage domain (approximately 19 residues long), and a C-terminal amphipathic cytoplasmic domain (54 residues long) facing inside the viral particle. 165 The M2 protein makes a proton channel involved in 2 virus replication functions. First, M2 serves as a proton selective ion channel, causing un-coating of the virus and exposure of its contents to the host cytoplasm. Second, it initiates viral replication and maturation of the haemagglutinin glycoprotein. 166, 167 In addition, the M2 protein is necessary and sufficient to block and inhibit autophagy (autophagosome maturation) and to trigger autophagy initiation. 48, 168 IAV takes advantage of autophagy inhibition. Autophagy inhibition hides IAV from immune attack despite not being useful for its replication. 48 The first 60 amino acids of M2 seem sufficient for inhibition of autophagosome maturation after binding to
Beclin-1. The specific inhibitor of the M2 H + channel, amantadine,
could not abrogate the inhibition of autophagy flux. This suggests that a block of autophagosome maturation does not involve M2 ion channel activity. Thus, the main functional part of the M2 protein is believed to be located within the internal domain that is responsible for proton conductive activity. 48 The mTOR signaling pathway negatively regulates autophagy. 169, 170 The phosphorylated form of the effector protein kinase mTOR is known to inhibit autophagy. 171 It has been proposed that the highly pathogenic avian influenza virus H5N1 induces autophagy by suppressing phosphorylated mTOR signaling. Thus, inhibition of autophagy could reduce H5N1-mediated cellular damage. 172 In terminal autophagy, mTORC2 upregulates p70S6K activity (the original natural substrate of mTORC1) required for LC3-II formation. Interestingly, when the complex mTORC2/p70S6K blocks lethal autophagy in the absence of apoptosis, drug inhibitors of lethal autophagy limit viral production in cells. 173 Increased autophagy shows altered autophagy signaling with increased mTORC1 and PI3K/mTORC2 activity and p70S6K phosphorylation. Blocking PI3K, mTORC2, or p70S6K activity prevents lethal autophagy and decreases infectious virus production. 173 Pan H et al (2914) reported that the activation of NF-k B signaling promoted H5N1 pseudotyped particles-induced autophagosome formation both in human lung epithelial cell lines and mouse lung tissues.
The positive feedback between autophagy and NF-k B and p38 MAPK signaling cascades could be an important mechanism contributing to H5N1 pseudotyped particles-induced lung inflammation. 174 Autophagy also performs as a key mechanism contributing to the inflammatory responses induced by H1N1 and H9N2. 175 Ectopic Pgranules autophagy protein 5 homolog (EPG5), which is essential for basal autophagy and functions of ATG genes complex in the formation of degradative autolysosomes, 176 regulates basal expression of multiple cytokines in the lung. Epg5 deficiency in myeloid cells in the lung causes an increase in IL-1b, IL-6, and IL-13 cytokines in lung macrophages.
Optimal cytokine levels exert protective effects against viral replication, thus enhancing the innate immune response to influenza. 176, 177 One study demonstrated that the activation of the PI3K/AKT pathway, which is closely related to the autophagic process, has a biphasic effect on influenza virus replication. 178 Deficiency in autophagy causes impaired survival of memory CD8 + T cells during infection with influenza virus. 179 Delayed apoptosis and highly stimulated autophagy were observed in IAV-infected cells. 180 In of its proton channel function. 160, 185, 186 Targeting cellular proteins could be effective in fighting influenza infections. To harness the full potential of this strategy, we need a greater understanding of the host intracellular pathways that influenza viruses use to replicate. 151 The mechanism that blocks autophagosome-lysosome fusion by the virus requires particular focus on its molecular details.
| Other respiratory viruses and autophagy
Coronaviruses, which infect a variety of hosts from human to birds, mainly cause mild respiratory infections, with the exception of severe acute respiratory syndrome coronavirus (SARS-CoV). 187 The replication. This may favor coronavirus infection by compromising the ability of autophagosomes to deliver viral components to lysosomes for degradation. 189 As evidenced by the large quantity of information gathered here, the relationship between viruses and autophagy is complex, 190 and fundamental mechanisms of autophagy involvement in viral infection are still in being elucidated.
| PERSPECTIVE
The autophagy pathway interacts with viruses. As a result of co-evolution, viruses developed numerous approaches to usurp the host autophagy system. The effect of autophagy on virus fate is time dependent and may play both pro-viral and antiviral roles during the multiplication and virus pathogenesis stages.
Autophagy is a determining factor when considering negativesense RNA viruses such as influenza viruses. A study by our research team showed that when autophagy induction is promoted before virus infection, virus titer enhanced significantly 24 hours post-infection, but it was not significant 48 hours post-infection. In contrast when autophagy formation is induced after virus infection, the virus replication was inhibited 24 and 48 hours post-infection. 191 Additionally, we showed that inhibition of autophagy using 3-MA significantly reduced viral replication. 191 In chronic HCV infection, selectively autophagy induction downregulates the IFN-α receptor-1 chain and the expression of the nucleoside transporters ENT1 and CNT1, thus leading to drug resistance. 86 with the autophagy factor LC3, suggesting that autophagy promoted productive Gag processing and that viral particles were produced in macrophages. 116 
| CONCLUSION
In this review, we summarize the multifaceted roles of autophagy in normal physiology and viral infection and pathogenesis (Table 1) . We highlight recent advances in understanding the relationship between autophagy and viral infection, and how autophagy plays dual roles in the disease progression. These data provide an overview of the molecular mechanisms that underlie autophagy, the role of this pathway in the pathogenesis of viruses, and strategies for therapeutic modulation. -HCV triggers lipoprotein degradation through lipophagy.
84
-HCV causes mitochondrial damage and oxidative stress, and impaired mitochondria are selectively eliminated mitophagy.
75
-NS5B/ATG5 interaction could be necessary for the establishment of HCV replication. 79 HCV-NS3 induces autophagy in an IRGM-dependent pathway. 62 HCV activates a selective autophagy for lipids (lipophagy) protects cells from an excessive lipid accumulation.
13
---HBV -the X protein of HBV interacts to, and induces, both phosphatidylinositol-3-kinase class 3 (PI3KC3) and deathassociated protein kinase (DAPK), activating autophagic signaling.
193
-autophagy inhibits tumorigenesis of HBV-associated Hepato cellular carcinoma (HCC) by degradation of microRNA-224.
92
-HBV small surface protein (SHB) activates autophagy.
201
-HBV X protein blocks autophagic degradation via inhibition of lysosomes.
202
Rotavirus -rotavirus NSP4 cause to release of calcium from the ER lumen, triggering autophagic signaling.
64
---HIV -Tat: Tat enhances autophagic degradation through increasing fusion process in neurons.
127
-Gag: Gag macrophages Gag-derived proteins co-localized and interacted with the autophagy factor LC3, and autophagy promoted productive Gag processing.
116
-Env: Env attaches to CXCR4 and leads to autophagy triggers cell death in neurons and uninfected T cells.
122
-Env induces autophagy and promotes autophagic T cell death, in bystander T cell.
123
-Nef: Nef induces autophagy in an IRGM-dependent pathway.
62
-Nef serves as an "antiautophagic maturation factor" and blocks the late proteolytic stage of autophagy.
116
-Nef mimics Baf A1 and blocks the formation of autophagolysosome in human astrocytes.
203
-Tat suppressed IFN-γ-induced autophagy in human macrophages.
130
-Tat blocks autophagy through Src-Akt and STAT3 signaling in uninfected macrophages and monocytes. 60 Influenza virus -NS1 is able to upregulate autophagy. 163 -proteolytic cleavage of viral HA activates autophagy.
-M2 blocks autophagosome-lysosome fusion by means of its viroporin activity. 48 Manipulation of autophagy heralds the potential for highly effective treatments for a wide range of clinical diseases, including both bacterial and viral infections as well as autoimmune and inflammatory disease states which deserve attention. Although our knowledge of the autophagy pathway is quickly progressing, there is still much to be learned regarding the specific molecules that regulate this pathway and the mechanisms by which viruses target these molecules to facilitate their replication. Further investigations are required to be examined in preclinical and clinical trials.
